(9ci)-2-氨基-1-环戊烯-1-羧酸甲酯 | 52909-60-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 乙烯基酰胺
• 中文名称: (9ci)-2-氨基-1-环戊烯-1-羧酸甲酯
• 中文别名: 2-氨基环戊-1-烯甲酸甲酯
• 英文名称: methyl 2-aminocyclopent-1-enecarboxylate
• 英文别名: methyl 2-aminocyclopentene-1-carboxylate
• CAS: 52909-60-1
• 化学式: C₇H₁₁NO₂
• mdl: MFCD19204033
• 分子量: 141.17
• InChiKey: OARCSIKUSBVKAW-UHFFFAOYSA-N

物化性质

• 熔点：
  95-96 °C(Solv: methanol (67-56-1))
• 沸点：
  246.4±39.0 °C(Predicted)
• 密度：
  1.146±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.571
• 拓扑面积：
  52.3
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2922499990

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-cyclopent-1-enecarboxylic acid methyl ester
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-cyclopent-1-enecarboxylic acid methyl ester
CAS number: 52909-60-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, under −20◦C.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H11NO2
Molecular weight: 141.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (9ci)-2-氨基-1-环戊烯-1-羧酸甲酯 在 甲酸铵 、 乙酸酐 、 formamide 作用下， 反应 20.0h， 生成 1,5,6,7-四氢环戊并[d]嘧啶-4-酮
  参考文献：
  名称：

  Structure–Activity Relationship and in Vitro and in Vivo Evaluation of the Potent Cytotoxic Anti-microtubule Agent N-(4-Methoxyphenyl)-N,2,6-trimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-aminium Chloride and Its Analogues As Antitumor Agents

  摘要：

  A series of 21 substituted cyclopenta[d]pyrimidines were synthesized as an extension of our discovery of the parent compound (+/-)-1 center dot HCl as an anti-microtubule agent. The structure activity relationship indicates that the N-methyl and a 4N-methoxy groups appear important for potent activity. In addition, the 6-substituent in the parent analogue is not necessary for activity. The most potent compound 30. HCl was a one to two digit nanomolar inhibitor of most tumor cell proliferations and was up to 7-fold more potent than the parent compound (+/-)-1 center dot HCl. In addition, 30 center dot HCl inhibited cancer cell proliferation regardless of Pgp or beta III-tubulin status, both of which are known to cause clinical resistance to several antitubulin agents. In vivo efficacy of 30 center dot HCl was demonstrated against a triple negative breast cancer xenograft mouse model. Compound 30 center dot HCl is water-soluble and easily synthesized and serves as a lead compound for further preclinical evaluation as an

  DOI：

  10.1021/jm400639z
• 作为产物：
  描述：

  2-甲氧羰基环戊酮 在 ammonium acetate 作用下， 以 甲醇 为溶剂， 反应 60.0h， 生成 (9ci)-2-氨基-1-环戊烯-1-羧酸甲酯
  参考文献：
  名称：

  用于β-脱氢氨基酸衍生物加氢的实用铑膦催化剂的开发

  摘要：

  已经研究了铑催化的各种β-脱氢氨基酸衍生物的不对称氢化，以产生光学活性的β-氨基酸。手性单齿4,5-二氢-3 H-二萘并吡啶类易配体已被轻松调配，并且可在多至10 g的范围内使用。对映选择性主要取决于磷原子上取代基的性质以及底物的结构。应用了高达94％ee的优化条件。

  DOI：

  10.1021/op0602270

文献信息

• Niacin receptor agonists, compositions containing such compounds and methods of treatment
  申请人：Raghavan Subharekha

  公开号：US20060293364A1

  公开（公告）日：2006-12-28

  The present invention encompasses compounds of Formula I: as well as pharmaceutically acceptable salts and hydrates thereof, that are useful for treating atherosclerosis, dyslipidemias and the like. Pharmaceutical compositions and methods of use are also included.

  本发明涵盖了Formula I的化合物： 以及其药用可接受的盐和水合物，用于治疗动脉粥样硬化、血脂异常等疾病。药物组合物和使用方法也包括在内。
• 一种抗肥胖症化合物及其制备方法和应用
  申请人：中山大学

  公开号：CN107721982B

  公开（公告）日：2019-12-03

  本发明涉及一种抗肥胖症化合物及其制备方法和应用，所述化合物的结构式如式（Ⅰ）、式（Ⅱ）或式（Ⅲ）所示：。本发明提供的抗肥胖症化合物具有较好的降脂活性，可以有效抑制脂肪细胞分化，降低脂肪细胞内脂质水平，稳定性好，毒性低；另外本发明可通过三步法制备得到上述抗肥胖症化合物，该制备过程简单，反应步骤少、时间短，后处理容易。
• Enantioselective Hydrogenation of Tetrasubstituted Olefins of Cyclic β-(Acylamino)acrylates
  作者：Wenjun Tang、Shulin Wu、Xumu Zhang

  DOI：10.1021/ja035777h

  日期：2003.8.1

  Hydrogenation of a series of cyclic beta-(acylamino)acrylates with tetrasubstituted olefins has been accomplished successfully with the use of Ru catalysts with chiral biaryl ligands such as C3-TunaPhos, and up to over 99% ee's have been achieved. This methodology provides an efficient catalytic method for the synthesis of both cis and trans chiral cyclic beta-amino acid derivatives.

  使用具有手性联芳基配体（如 C3-TunaPhos）的 Ru 催化剂成功地完成了一系列环状 β-（酰氨基）丙烯酸酯与四取代烯烃的氢化，并且已实现高达 99% 以上的 ee。该方法为顺式和反式手性环状β-氨基酸衍生物的合成提供了一种有效的催化方法。
• Silica Gel‐mediated Synthesis of β‐Enamino Esters and its Application for the Synthesis of Indeno 4‐Hydroxypyridin‐2(1H)‐Ones
  作者：Soong‐Hyun Kim、Seri Bae、Eun Bi Ko、Ga Young Park、Eunhye Lee、Hee Jong Hwang、Chun Young Im、Minsoo Song

  DOI：10.1002/bkcs.11676

  日期：2019.3

  The full scope of SiO2‐based condensation of aliphatic or aromatic amines and β‐keto esters to give β‐enamino esters was examined. Functionalized linear β‐enamino esters were easily obtained from SiO2‐based condensation of β‐keto esters and amines only after simple filtration. It was also demonstrated that cyclic β‐enamino esters with 99% purity can be prepared in a practically large scale (60 g) without

  考察了脂肪族或芳香族胺与β-酮酯的SiO 2基缩合反应生成β-烯氨基酯的全部范围。仅在简单过滤后，才能通过基于SiO 2的β-酮酸酯和胺的缩合反应轻松获得官能化的线性β-烯胺酯。还证明，无需使用硅胶柱色谱法，就可以大规模（60 g）制备纯度为99％的环状β-烯胺酯。通过制备可药用的茚基-4-羟基吡啶2-2（1H）-one类似物11来加强本方法的实用性。
• Synthesis of febrifugine derivatives and development of an effective and safe tetrahydroquinazoline-type antimalarial
  作者：Haruhisa Kikuchi、Seiko Horoiwa、Ryota Kasahara、Norimitsu Hariguchi、Makoto Matsumoto、Yoshiteru Oshima

  DOI：10.1016/j.ejmech.2014.01.036

  日期：2014.4

  quinazoline alkaloid isolated from Dichroa febrifuga roots, shows powerful antimalarial activity against Plasmodium falciparum. Although the use of ferifugine as an antimalarial drug has been precluded because of its severe side effects, its potent antimalarial activity has stimulated medicinal chemists to pursue its derivatives instead, which may provide valuable leads for novel antimalarial drugs. In

  Febrifugine是一种从费氏地蝇（Dichroa febrifuga）根中分离出来的喹唑啉生物碱，对恶性疟原虫具有强大的抗疟活性。尽管由于其严重的副作用已排除了将阿昔福林用作抗疟药，但其强大的抗疟活性已刺激药用化学家们追求其衍生物，这可能为新型抗疟药提供了有价值的线索。在目前的研究中，我们合成了新的非溴夫定衍生物，并评估了它们的体外和体内抗疟活性，以开发出更有效，更安全的抗疟药物。结果，我们提出了四氢喹唑啉型衍生物作为安全有效的抗疟候选药。